Recall InfoLink Logo

Recall Details

Dr. Reddy’s Recalls Prescription Drug Blister Packages Due to Risk of Poisoning


Imatinib Mesylate Tablets 100 mg, Imatinib Mesylate Tablets 400 mg, Pregabalin Capsules 50 mg, Pregabalin Capsules 75 mg, Pregabalin Capsules 100 mg, Pregabalin Capsules 150 mg, Sevelamer Carbonate Tablets 800 mg, Tadalafil Tablets 5 mg and Tadalafil Tablets 20 mg


The products are prescription medications that were labeled and distributed by Dr. Reddy’s for institutional use only. The prescription medications were distributed by third party wholesalers to retail pharmacies and could have been dispensed to consumers. The packaging of the products is not child resistant and can pose a risk of poisoning if the contents are swallowed by young children.

Brand Name:

Dr. Reddy’s

Company Name:

Dr. Reddy’s Laboratories, Inc.

Company Announcement:

Company Announcement

Recall Details


This recall involves blister packages of prescription medications.  The name and strength of the medication, “For Institutional Use only,” “Rx Only,” lot number and expiration date are printed on the outside of the package as well as on the individual blister units.  The Dr. Reddy’s logo and NDC number are printed on the outside of the package.


Consumers should immediately store the recalled medications in a safe location out of reach of children and contact Dr. Reddy’s for a full refund.


No incidents or injuries have been reported.

Sold At:

Beginning in 2018, Dr. Reddy’s sold the recalled medications to wholesalers.  Ultimately, these medications could have been sold to consumers at retail pharmacies in the United States at prices varying based on quantities prescribed, health insurance terms, and other factors.


Dr. Reddy’s Laboratories, Ltd., of India


Dr. Reddy’s Laboratories, Inc., of Princeton, N.J.

Manufactured In:


Recall number:


Product Photos

No items found.

Be prepared to handle a recall like this one.